
Amal bags €21.2m financing
All existing investors – Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment Fund, VI Partners, High-Tech Gründerfonds, and...

First immunotolerant allogenic cell transplants revealed
Though induced pluripotent stem cells (iPSCs) provide a cell source that propagates unlimited and can be differentiated in any tissue of the body,...

Afyren raises €21m to launch production plant
Together with its historical shareholders AFY Partners and Sofimac Régions Afyren has raised more than €60m to move its zero-waste fermentation...

Tissue specific tumour transition needs few cells
Anja Voss-Böhme from University Dresden and researchers at the German Cancer Center in Heidelberg used a model that links epigenetic and genetic...

AI provides face read-out of genetic diseases
A self-learning algorithm created by US-Israelian company FDNA identified rare genetic syndromes with high accuracy following training on tens of...

SOBI and AstraZeneca in US$2bn+ deal on RSV antibodies
Though Synagis biosimilars are under development at South Korean Celltrion, Mabxience and Chinese iBio, palivizumab is currently the only...

New cheap CRS-blockers at the horizon
In mice, the team headed by Bert Vogelstein and Shibin Zhou from Johns-Hopkins University in Baltimore demonstrated that severe...